AdjustNOW
Personalized dosing for complex pharmacokinetics using Bayesian estimation and TDM.
Current status
In development. Pilot not started. Runs only on simulated data today; not used with patients.
Product in development: not yet available to purchase.
Status reviewed on November 7, 2026.
What we are building
- Bayesian estimation
- TDM support
- Offline on Android and iOS
New
Dose safety rules verified before they are shown; they do not replace clinical judgment.